CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit

First Page		Document Content
Date: 2016-06-03 12:14:22 Chemistry Organic chemistry Clinical medicine Lung cancer Quinazolines Tyrosine kinase receptors Tyrosine kinase inhibitors Amines Brigatinib Gefitinib T790M Non-small-cell lung carcinoma		CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit Add to Reading List Source URL: gotoper-com.s3.amazonaws.com Download Document from Source Website File Size: 236,30 KB Share Document on Facebook

	Microsoft Word - abstracts_compiled.doc DocID: 1rn3E - View Document
	Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent DocID: 1rdcC - View Document
	CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit DocID: 1qVsW - View Document
	2014 Annual Report Centre for Cancer Biology DocID: 1qRyU - View Document
	Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U DocID: 1qMPs - View Document